Value
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 6.8 |
| P/S | 7.8 |
| EV/EBITDA | 1.4 |
| Fwd P/E | 7.9 |
| PEG | 4.1 |
| Analyst target | 6.0 |
- ▸Forward P/E: 15.3x
- ▸PEG: 2.39
HLN · Why this verdict
Why Haleon (HLN) is rated HOLD
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictHOLD
Overall score5.6/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Haleon offers a financially sound consumer health franchise with strong margins and a favorable risk/reward setup, but a death cross and sustained negative price momentum block near-term entry; the thesis requires a technical reversal before the asymmetric upside becomes actionable.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The business carries operating margins of 15% and a Piotroski F-Score of 8 out of 9, reflecting healthy profitability, strong balance-sheet discipline, and financial quality that ranks above the sector average on most solvency and efficiency metrics. Quality breakdown | Operating margins hold at or above 15% and the Piotroski F-Score remains 8 or 9 across the next four reporting periods. | →Stable |
| CounterRevenue and earnings growth scores are soft, and the peer growth rank is below average; strong quality metrics without a growth catalyst may delay multiple expansion indefinitely. | ||
The stock trades below its 200-day moving average with volume distribution trending against holders and a death cross in place, indicating near-term selling pressure that has not yet abated despite improving MACD readings and a neutral RSI near 45. Warnings | On-balance volume shifts to accumulation and the stock reclaims its 200-day moving average, sustained for at least four consecutive weeks within 12 months. | →Stable |
| CounterThe MACD is improving and the RSI sits at a neutral 45, both consistent with an early recovery setup; the death cross may prove a lagging indicator if the fundamental re-rating begins before the technical cross resolves. | ||
With approximately 12.6% headroom to the analyst consensus target of $10.21 and a risk/reward of roughly 3.4-to-1 in favor of upside, the price geometry provides a favorable asymmetric setup for investors who can tolerate near-term momentum weakness. Price targets | Price advances toward $10.21 within 12 months as the technical setup improves and the upside is realized. | →Stable |
| CounterThe PEG ratio at 2.38 is elevated relative to the growth profile, which may prompt downward analyst revisions and compress the apparent upside as the target moves lower. | ||
The four-quarter earnings record is uneven — a recent in-line result, then a beat, a miss, and an in-line in the three quarters before it — producing an average positive surprise of under 2% that leaves the trajectory uncertain rather than reliably positive. Earnings | Two consecutive beats with positive surprise percentages over the next two reporting periods establish a more consistent delivery pattern. | →Stable |
| CounterAn average surprise barely above zero means the business is broadly tracking expectations, which limits downside from an earnings-driven derating even if individual quarter variability persists. | ||
The business carries operating margins of 15% and a Piotroski F-Score of 8 out of 9, reflecting healthy profitability, strong balance-sheet discipline, and financial quality that ranks above the sector average on most solvency and efficiency metrics.
→StableQuality breakdown
- Expectation
- Operating margins hold at or above 15% and the Piotroski F-Score remains 8 or 9 across the next four reporting periods.
CounterRevenue and earnings growth scores are soft, and the peer growth rank is below average; strong quality metrics without a growth catalyst may delay multiple expansion indefinitely.
The stock trades below its 200-day moving average with volume distribution trending against holders and a death cross in place, indicating near-term selling pressure that has not yet abated despite improving MACD readings and a neutral RSI near 45.
→StableWarnings
- Expectation
- On-balance volume shifts to accumulation and the stock reclaims its 200-day moving average, sustained for at least four consecutive weeks within 12 months.
CounterThe MACD is improving and the RSI sits at a neutral 45, both consistent with an early recovery setup; the death cross may prove a lagging indicator if the fundamental re-rating begins before the technical cross resolves.
With approximately 12.6% headroom to the analyst consensus target of $10.21 and a risk/reward of roughly 3.4-to-1 in favor of upside, the price geometry provides a favorable asymmetric setup for investors who can tolerate near-term momentum weakness.
→StablePrice targets
- Expectation
- Price advances toward $10.21 within 12 months as the technical setup improves and the upside is realized.
CounterThe PEG ratio at 2.38 is elevated relative to the growth profile, which may prompt downward analyst revisions and compress the apparent upside as the target moves lower.
The four-quarter earnings record is uneven — a recent in-line result, then a beat, a miss, and an in-line in the three quarters before it — producing an average positive surprise of under 2% that leaves the trajectory uncertain rather than reliably positive.
→StableEarnings
- Expectation
- Two consecutive beats with positive surprise percentages over the next two reporting periods establish a more consistent delivery pattern.
CounterAn average surprise barely above zero means the business is broadly tracking expectations, which limits downside from an earnings-driven derating even if individual quarter variability persists.
Per-dimension breakdown
Quality
6.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 3.4 |
| ROA | 3.1 |
| Gross margin | 9.0 |
| Op margin | 9.3 |
| Net margin | 7.6 |
| Current ratio | 3.7 |
| FCF quality | 6.2 |
| Moat | 6.0 |
| Piotroski F | 8.9 |
- ▸Strong margins: 15%
- ▸Strong Piotroski F-Score: 8/9
Growth
6.3/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 2.7 |
| EPS growth | 10.0 |
Momentum
5.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 6.8 |
| OBV | 10.0 |
| MA position | 6.5 |
| Volume | 0.0 |
- ▸Volume accumulation (rising OBV)
- ▸Below 200-MA, MA slope flat
Sentiment
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 6.5 |
| Price target | 8.3 |
| erm sentiment | 5.0 |
- ▸Light analyst coverage (5.0) — signal dampened
- ▸Analyst upside: 26%
Insider
5.0/10data confidence 50%Peer rank
3.3/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.8 |
| quality rank | 5.9 |
| growth rank | 2.6 |
Technical
2.6/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.0 |
| support resistance | 0.2 |
| 52w position | 6.5 |
Risk (lower is worse)
7.9/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 9.9 |
| days to cover | 9.7 |
| volatility | 7.5 |
| implied vol | 7.3 |
| max pain risk | 3.0 |
| beta | 10.0 |
| debt equity | 7.9 |
- ▸Above max pain $2
Catalyst
4.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 3.3 |
| earnings timing | 5.0 |
| surprise avg | 3.4 |
| dividend safety | 6.0 |
- ▸Dividend: 209.0%
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more.
Engine technical detail
verdict_path:
L4:PATH_F_HOLDPassed (7)
- MOMENTUM:5.6>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:35d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:1.4<1.5@spot
Warning (1)
- DEATH_CROSS:momentum=5.6>=5.0 recovering
Reward-to-Risk
1.45
Upside
+9.7%
Downside
6.7%
Sizing output
AVOID
SetupRECOVERY — Death cross but MACD improving, RSI 58
EdgeNO_EDGE — No clear edge identified
SuitabilityMODERATE — Balanced profile
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:5.6>=5.5. Top dim: Risk (lower is worse) at 7.9; weakest: Technical at 2.6. No conviction either direction.
The strongest dimensions are Risk (lower is worse) at 7.9, Sentiment at 6.7, and Quality at 6.4; the weakest are Technical at 2.6, Peer rank at 3.3, and Catalyst at 4.5. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 1.45 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The stock trades below its 200-day moving average with volume distribution trending against holders and a death cross in place, indicating near-term selling pressure that has not yet abated despite improving MACD readings and a neutral RSI near 45.
Trip ifPrice closes above $10.21 and holds for 4 consecutive weeks, confirming momentum has recovered.
- P2The business carries operating margins of 15% and a Piotroski F-Score of 8 out of 9, reflecting healthy profitability, strong balance-sheet discipline, and financial quality that ranks above the sector average on most solvency and efficiency metrics.
Trip ifOperating margin falls below 12% for 2 consecutive reporting periods.
- P3With approximately 12.6% headroom to the analyst consensus target of $10.21 and a risk/reward of roughly 3.4-to-1 in favor of upside, the price geometry provides a favorable asymmetric setup for investors who can tolerate near-term momentum weakness.
Trip ifAnalyst consensus price target falls below $9.07 (the current price), eliminating the upside gap.
- P4The four-quarter earnings record is uneven — a recent in-line result, then a beat, a miss, and an in-line in the three quarters before it — producing an average positive surprise of under 2% that leaves the trajectory uncertain rather than reliably positive.
Trip ifEPS surprise exceeds 5% for 2 consecutive quarters, establishing a pattern of consistent delivery.